Johnson & Johnson (JNJ.N)
24 Apr 2015
* Says achieves 10 million dollar milestone in daratumumab collaboration with Janssen, a pharmaceutical company of Johnson & Johnson
WASHINGTON - U.S. industrial output posted its biggest drop in more than 2-1/2 years in March in part as oil and gas well drilling plummeted, highlighting the negative impact of lower crude prices and a strong dollar on the economy.
WASHINGTON, April 15 - U.S. industrial output posted its biggest drop in more than 2-1/2 years in March in part as oil and gas well drilling plummeted, highlighting the negative impact of lower crude prices and a strong dollar on the economy.
NEW YORK - The Dow and S&P 500 ended higher on Tuesday, helped by energy stocks and quarterly earnings reports that topped modest expectations following worries about a strong dollar.
- Healthcare conglomerate Johnson & Johnson cut its full-year profit forecast on Tuesday, saying it expected a strong dollar to keep hurting its international business.
* J&J expects to fend off Remicade biosimilar for nearly 3 years
NEW YORK, April 14 - U.S. stocks rose modestly on Tuesday as investors digested the initial major earnings of the first-quarter reporting season, which showed some weakness despite companies topping lowered expectations.
* Futures: Dow down 3 pts, S&P down 2 pts, Nasdaq up 1.5 pt (Updates with Wells results, retail sales data)
April 14 - Johnson & Johnson reported an 8.6 percent fall in quarterly profit as the impact of a strong dollar on overseas revenue offset growing sales of its mainstay older drugs.
SEATTLE - International Business Machines Corp, deepening its partnership with Apple Inc to make use of health information gathered by millions of Apple devices, is creating a unit dedicated to providing data analytics to the healthcare sector.
|General Electric Company (GE.N)||$26.80||--|
|Procter & Gamble Co (PG.N)||$81.00||--|
|Pfizer Inc. (PFE.N)||$35.27||--|
|Novartis AG (NOVN.VX)||CHF100.40||+0.60|
|Merck & Co., Inc. (MRK.N)||$57.60||--|
|Baxter International Inc. (BAX.N)||$71.14||--|
|Stryker Corporation (SYK.N)||$96.90||--|
|Boston Scientific Corporation (BSX.N)||$18.34||--|
|Zimmer Holdings, Inc. (ZMH.N)||$118.76||--|